Sweden's Klaria Pharma Raises SEK111 Million via Rights Issue

MT Newswires · 6d ago
12:38 AM EST, 11/16/2026 (MT Newswires) -- Klaria Pharma (KLAR.ST) raised 111.1 million kronor through a rights issue of 185,176,660 shares and 46,294,165 series TO1 warrants, with 37.3 million kronor to be paid by way of set-off against claims on the company. The Swedish pharmaceutical company said Nov. 13 that investors subscribed for 61.4% of the offering, representing 90.6 million kronor, while Vator Securities subscribed for an additional 20.5 million kronor under its underwriting commitment. The offering was 75.3% subscribed overall, generating cash proceeds of 73.8 million kronor before issue costs and loan repayments. Klaria expects issue costs of 10 million kronor, excluding underwriting fees. Full exercise of the warrants could raise a further 27.8 million kronor before costs, with trading in the warrants on Nasdaq First North Growth Market expected to begin on Nov. 30.